Kangyueda (stapokibart) - Keymed Biosciences
Xolair (omalizumab) - Roche, Novartis
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Nucala (mepolizumab) - GSK
Exdensur (depemokimab-ulaa) - GSK
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42682950
 
Hussain J Aljubran; Salma S Alsharhan
 
Sep 3, 2026
 
Prev Next